Sarah Sheehan is a Managing Associate at the Duke-Margolis Center for Health Policy working on biomedical innovation, medical product development, and regulatory science initiatives. Sarah’s work at the Center focuses primarily on issues related to the design and conduct of clinical trials.
Before joining Duke, Sarah was a Health Policy Analyst at the United States Government Accountability Office (GAO) and a Researcher at the Centers for Disease Control and Prevention (CDC). At GAO and CDC, Sarah’s research covered policies related to incentivizing the development of new antimicrobials and approaches to preventing healthcare-associated infections.
Melanie Bhatnagar, Sarah Sheehan, Isha Sharma, Gerri Baer, Dionna Green, Susan McCune, Steven Joffe, and Donna Snyder
Pediatrics, 2021Read More
Sarah Sheehan, Gerri Baer, Morgan Romine, Lynn Hudson, Robert Lim, Elektra Papadopoulos, Michelle Campbell, Gregory Daniel, Susan McCune
Monika Schneider, Susan Dentzer, Sarah Sheehan, Karley Whelan, Christina Silcox, Marianne Hamilton Lopez, Marta Wosińska, Mark McClellan
FDA postmarketing safety labeling changes: What have we learned since 2010 about impacts on prescribing rates, drug utilization, and treatment outcomes
Matthew Rosenberg, Sarah Sheehan, Esther Zhou, Ellen Pinnow, Jessica Burnell, Morgan Romine, Gerald Dal Pan
Mark McClellan, Gregory Daniel, Sarah Sheehan, Morgan Romine, Elizabeth Richardson, Jessica Burnell, Meredith Freed, Becky Briesacher, Stacie Dusetzina, Chester Good, Kenneth Hornbuckle, Joseph Ross